Laguitan, Erlinda G.
HRN: 22-11-11 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2022
CEFTRIAXONE 1G (VIAL)
10/24/2022
10/31/2022
IV
2g
OD
CAP MR
Waiting Final Action
10/24/2022
METRONIDAZOLE 500MG (TAB)
10/24/2022
10/31/2022
ORAL
750mg
TID
Amoebiasis
Waiting Final Action